Recent Finacing
Recent Raise
858 Therapeutics is a San Diego–based drug discovery company developing small-molecule oncology therapies—using proprietary biochemical, biophysical and cellular assays to target RNA-modifying proteins, innate immunity, and PARG (ETX-19477, Phase 1).
